Antiparkinsonian and antidepressant effects of high doses of bromocriptine
- 1 May 1983
- journal article
- research article
- Published by Elsevier BV in Journal of Affective Disorders
- Vol. 5 (2), 141-145
- https://doi.org/10.1016/0165-0327(83)90006-x
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Is the mesocortical dopaminergic system involved in Parkinson disease?Neurology, 1980
- Anti-depressive treatment in Parkinson's disease A CONTROLLED TRIAL OF THE EFFECT OF NORTRIPTYLINE IN PATIENTS WITH PARKINSON'S DISEASE TREATED WITH L-DOPAActa Neurologica Scandinavica, 1980
- Bromocriptine in affective disordersJournal of Affective Disorders, 1979
- BROMOCRIPTINE ASSOCIATED WITH A PERIPHERAL DOPAMINE BLOCKING AGENT IN TREATMENT OF PARKINSON'S DISEASEThe Lancet, 1979
- LONG-TERM TREATMENT OF PARKINSONISM WITH BROMOCRIPTINEThe Lancet, 1978
- Improvement of Parkinsonism in depressed patients treated with ECTAmerican Journal of Psychiatry, 1975
- Some psychological factors in ParkinsonismJournal of Neurology, Neurosurgery & Psychiatry, 1974
- Diagnostic Criteria for Use in Psychiatric ResearchArchives of General Psychiatry, 1972
- EFFECT OF L-DOPA ON DEPRESSIONThe Lancet, 1969
- Development of a Rating Scale for Primary Depressive IllnessBritish Journal of Social and Clinical Psychology, 1967